Special considerations and pitfalls for intracerebral bleeding followed COVID-19 case treated by ECMO.

Wael Osman Amer, Hussein Awad El Gharieb, Zakaria Ahmed, Hossam Ibrahim, Ahmed Alanazi, Mostafa Meshref

Open access · diamondAbstract read

In one paragraph

Article in Brain hemorrhages, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 81% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Wael Osman AmerNeurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Hussein Awad El GhariebNeurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Zakaria AhmedNeurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Hossam IbrahimKing Salman Armed Forces Hospital, Tabuk, Saudi Arabia.

Ahmed AlanaziTraining Internal Medicine Resident, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.

Mostafa MeshrefNeurology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Al-Azhar University · EGArmed Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated with ECMO was bleeding. COVID patients are at risk for intracerebral bleeding due to several factors, including the drug's action on ACE2 receptors, leading to hypertension, as well as hypercoagulability, dysregulated immune response, DIC, and the use of anticoagulants.

Indexed as

COVID-19Dysregulated immune responseECMOHypercoagulabilityICB

Identifiers

PMID37359506

DOI10.1016/j.hest.2023.06.001

PMCPMC10257510

OpenAlexW4380202504

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.